[
68
Ga]Ga-FAPI-46 PET/CT as an early indicator of complete remission in a patient treated with pembrolizumab for stage IV NSCLC
Eur J Nucl Med Mol Imaging
.
2024 Nov 7.
doi: 10.1007/s00259-024-06971-9.
Online ahead of print.
Authors
P E Borgonje
1
,
L M Andrews
2
,
J J G van den Brand
3
,
G J M Herder
3
,
J M H de Klerk
4
Affiliations
1
Department of Clinical Pharmacy, Meander Medical Center, Amersfoort, The Netherlands.
[email protected]
.
2
Department of Clinical Pharmacy, Meander Medical Center, Amersfoort, The Netherlands.
3
Department of Pulmonology, Meander Medical Center, Amersfoort, The Netherlands.
4
Department of Nuclear Medicine, Meander Medical Center, Amersfoort, The Netherlands.
PMID:
39508899
DOI:
10.1007/s00259-024-06971-9
No abstract available
Grants and funding
Vrienden van Meander/Vrienden van Meander